The association of adiponectin allele 45T/G and -11377C/G polymorphisms with Type 2 diabetes and rosiglitazone response in Chinese patients
点击次数:
所属单位:
Department of Pharmacy, Fujian Provincal Hospital
教研室:
Department of Pharmacy,Fujian Provincal Hospital
发表刊物:
british journal of clinical pharmacology
刊物所在地:
britsh
项目来源:
National Natural Science Foundation of China
关键字:
C-11377G polymorphism, T45G polymorphism, adiponectin, diplotype, rosiglitazone efficacy, Type 2 dia
摘要:
Abstract
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT:
Rosiglitazone is able to increase serum adiponectin levels significantly in Type 2 diabetic patients. :The role of genetic factors that determine the marked interindividual variability in glucose-lowering efficacy of rosiglitazone in Chinese patients is not known. The current study was designed to evaluate the impact of the adiponectin common allele 45T/G and -11377C/G polymorphisms on the response to rosiglitazone monotherapy in Chinese patients with Type 2 diabetes (T2D).
WHAT THIS STUDY ADDS:
The genetic polymorphisms of adiponectin allele
合写作者:
Liu ZQ*, Wu J, Zhou HH, Guo ZW, Liu YZ, Liu HL, Yin JY, Gong ZC#, Sun H#*
论文类型:
基础研究
论文编号:
DOI:10.1111/j.1365-2125.2008.03145.x
学科门类:
临床医学
文献类型:
J
卷号:
65
期号:
6
页面范围:
917-926
ISSN号:
1365-2125
是否译文:
否
附件: